Burns bought 25000 on July 14th after news on July 13th: EntreMed Contracts With Elan to Produce Panzem(R) Clinical Material <A HREF="http://investor.entremed.com/ireye/ir_site.zhtml?ticker=ENMD&script=460&layout=-6&item_id=590408" target="_blank">http://investor.entremed.com/ireye/ir_site.zhtml?ticker=ENMD&script=460&layout=-6&item_i...</A> Next news on July 27th EntreMed to Announce Second Quarter 2004 Financial Results <A HREF="http://investor.entremed.com/ireye/ir_site.zhtml?ticker=ENMD&script=460&layout=-6&item_id=596670" target="_blank">http://investor.entremed.com/ireye/ir_site.zhtml?ticker=ENMD&script=460&layout=-6&item_i...</A> Burns bought 10000 shares on September 24th. <A HREF="http://ccbn.tenkwizard.com/filing.php?repo=tenk&ipage=3006953&doc=1&total=&attach=ON..." target="_blank">http://ccbn.tenkwizard.com/filing.php?repo=tenk&ipage=3006953&doc=1&total=&attach=ON...</A>. Then news on September 29th: EntreMed Presents Additional Panzem(R) (2ME2) Preclinical Data at EORTC-NCI-AACR Symposium <A HREF="http://investor.entremed.com/ireye/ir_site.zhtml?ticker=ENMD&script=410&layout=-6&item_i.." target="_blank">http://investor.entremed.com/ireye/ir_site.zhtml?ticker=ENMD&script=410&layout=-6&item_i...</A>. Then stock option for 100000 shares on December 20th. <A HREF="http://ccbn.tenkwizard.com/filing.php?repo=tenk&ipage=3160649&doc=1&total=&attach=ON..." target="_blank">http://ccbn.tenkwizard.com/filing.php?repo=tenk&ipage=3160649&doc=1&total=&attach=ON...</A>. Then news on December 29th: EntreMed Announces $14 Million Private Placement with Leading Biotech Institutional Investors <A HREF="http://investor.entremed.com/ireye/ir_site.zhtml?ticker=ENMD&script=410&layout=-6&item_i.." target="_blank">http://investor.entremed.com/ireye/ir_site.zhtml?ticker=ENMD&script=410&layout=-6&item_i...</A>.